Hepatocyte-specific O-GlcNAc transferase ...
Document type :
Article dans une revue scientifique: Article original
PMID :
Permalink :
Title :
Hepatocyte-specific O-GlcNAc transferase downregulation ameliorates nonalcoholic steatohepatitis by improving mitochondrial function.
Author(s) :
Gonzalez-Rellan, M. J. [Auteur]
Universidade de Santiago de Compostela [España] = University of Santiago de Compostela [Spain] = Université de Saint-Jacques-de-Compostelle [Espagne] [USC]
Parracho, T. [Auteur]
Universidade de Santiago de Compostela [España] = University of Santiago de Compostela [Spain] = Université de Saint-Jacques-de-Compostelle [Espagne] [USC]
Heras, V. [Auteur]
Rodriguez, A. [Auteur]
Fondevila, M. F. [Auteur]
Novoa, E. [Auteur]
Lima, N. [Auteur]
Varela-Rey, M. [Auteur]
Senra, A. [Auteur]
Chantada-Vazquez, M. D. [Auteur]
Ameneiro, C. [Auteur]
Bernardo, G. [Auteur]
Fernandez-Ramos, D. [Auteur]
Lopitz-Otsoa, F. [Auteur]
Bilbao, J. [Auteur]
Guallar, D. [Auteur]
Fidalgo, M. [Auteur]
Bravo, S. [Auteur]
Dieguez, C. [Auteur]
Martinez-Chantar, M. L. [Auteur]
Millet, O. [Auteur]
Mato, J. M. [Auteur]
Schwaninger, M. [Auteur]
Prevot, Vincent [Auteur]
Lille Neurosciences & Cognition (LilNCog) - U 1172
Crespo, J. [Auteur]
Frühbeck, G. [Auteur]
Iruzubieta, P. [Auteur]
Nogueiras, R. [Auteur]
Universidade de Santiago de Compostela [España] = University of Santiago de Compostela [Spain] = Université de Saint-Jacques-de-Compostelle [Espagne] [USC]
Universidade de Santiago de Compostela [España] = University of Santiago de Compostela [Spain] = Université de Saint-Jacques-de-Compostelle [Espagne] [USC]
Parracho, T. [Auteur]
Universidade de Santiago de Compostela [España] = University of Santiago de Compostela [Spain] = Université de Saint-Jacques-de-Compostelle [Espagne] [USC]
Heras, V. [Auteur]
Rodriguez, A. [Auteur]
Fondevila, M. F. [Auteur]
Novoa, E. [Auteur]
Lima, N. [Auteur]
Varela-Rey, M. [Auteur]
Senra, A. [Auteur]
Chantada-Vazquez, M. D. [Auteur]
Ameneiro, C. [Auteur]
Bernardo, G. [Auteur]
Fernandez-Ramos, D. [Auteur]
Lopitz-Otsoa, F. [Auteur]
Bilbao, J. [Auteur]
Guallar, D. [Auteur]
Fidalgo, M. [Auteur]
Bravo, S. [Auteur]
Dieguez, C. [Auteur]
Martinez-Chantar, M. L. [Auteur]
Millet, O. [Auteur]
Mato, J. M. [Auteur]
Schwaninger, M. [Auteur]
Prevot, Vincent [Auteur]

Lille Neurosciences & Cognition (LilNCog) - U 1172
Crespo, J. [Auteur]
Frühbeck, G. [Auteur]
Iruzubieta, P. [Auteur]
Nogueiras, R. [Auteur]
Universidade de Santiago de Compostela [España] = University of Santiago de Compostela [Spain] = Université de Saint-Jacques-de-Compostelle [Espagne] [USC]
Journal title :
Molecular metabolism
Abbreviated title :
Mol Metab
Volume number :
75
Pages :
101776
Publisher :
Elsevier
Publication date :
2023-07-16
ISSN :
2212-8778
English keyword(s) :
NAFLD
Mitochondrial dysfunction
O-GlcNAcylation
Mitochondrial dysfunction
O-GlcNAcylation
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
Objective
O-GlcNAcylation is a post-translational modification that directly couples the processes of nutrient sensing, metabolism, and signal transduction, affecting protein function and localization, since the O-linked ...
Show more >Objective O-GlcNAcylation is a post-translational modification that directly couples the processes of nutrient sensing, metabolism, and signal transduction, affecting protein function and localization, since the O-linked N-acetylglucosamine moiety comes directly from the metabolism of glucose, lipids, and amino acids. The addition and removal of O-GlcNAc of target proteins are mediated by two highly conserved enzymes: O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT) and O-GlcNAcase (OGA), respectively. Deregulation of O-GlcNAcylation has been reported to be associated with various human diseases such as cancer, diabetes, and cardiovascular diseases. The contribution of deregulated O-GlcNAcylation to the progression and pathogenesis of NAFLD remains intriguing, and a better understanding of its roles in this pathophysiological context is required to uncover novel avenues for therapeutic intervention. By using a translational approach, our aim is to describe the role of OGT and O-GlcNAcylation in the pathogenesis of NAFLD. Methods We used primary mouse hepatocytes, human hepatic cell lines and in vivo mouse models of steatohepatitis to manipulate O-GlcNAc transferase (OGT). We also studied OGT and O-GlcNAcylation in liver samples from different cohorts of people with NAFLD. Results O-GlcNAcylation was upregulated in the liver of people and animal models with steatohepatitis. Downregulation of OGT in NAFLD-hepatocytes improved diet-induced liver injury in both in vivo and in vitro models. Proteomics studies revealed that mitochondrial proteins were hyper-O-GlcNAcylated in the liver of mice with steatohepatitis. Inhibition of OGT is able to restore mitochondrial oxidation and decrease hepatic lipid content in in vitro and in vivo models of NAFLD. Conclusions These results demonstrate that deregulated hyper-O-GlcNAcylation favors NAFLD progression by reducing mitochondrial oxidation and promoting hepatic lipid accumulation.Show less >
Show more >Objective O-GlcNAcylation is a post-translational modification that directly couples the processes of nutrient sensing, metabolism, and signal transduction, affecting protein function and localization, since the O-linked N-acetylglucosamine moiety comes directly from the metabolism of glucose, lipids, and amino acids. The addition and removal of O-GlcNAc of target proteins are mediated by two highly conserved enzymes: O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT) and O-GlcNAcase (OGA), respectively. Deregulation of O-GlcNAcylation has been reported to be associated with various human diseases such as cancer, diabetes, and cardiovascular diseases. The contribution of deregulated O-GlcNAcylation to the progression and pathogenesis of NAFLD remains intriguing, and a better understanding of its roles in this pathophysiological context is required to uncover novel avenues for therapeutic intervention. By using a translational approach, our aim is to describe the role of OGT and O-GlcNAcylation in the pathogenesis of NAFLD. Methods We used primary mouse hepatocytes, human hepatic cell lines and in vivo mouse models of steatohepatitis to manipulate O-GlcNAc transferase (OGT). We also studied OGT and O-GlcNAcylation in liver samples from different cohorts of people with NAFLD. Results O-GlcNAcylation was upregulated in the liver of people and animal models with steatohepatitis. Downregulation of OGT in NAFLD-hepatocytes improved diet-induced liver injury in both in vivo and in vitro models. Proteomics studies revealed that mitochondrial proteins were hyper-O-GlcNAcylated in the liver of mice with steatohepatitis. Inhibition of OGT is able to restore mitochondrial oxidation and decrease hepatic lipid content in in vitro and in vivo models of NAFLD. Conclusions These results demonstrate that deregulated hyper-O-GlcNAcylation favors NAFLD progression by reducing mitochondrial oxidation and promoting hepatic lipid accumulation.Show less >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
Université de Lille
Inserm
CHU Lille
Inserm
CHU Lille
Collections :
Submission date :
2024-02-17T22:11:05Z
2024-12-11T09:56:57Z
2024-12-11T09:56:57Z
Files
- 1-s2.0-S2212877823001102-main.pdf
- Version éditeur
- Open access
- Access the document
Except where otherwise noted, this item's license is described as Attribution-NonCommercial 3.0 United States